Browsing "Journal Papers" by Keyword : SARS-CoV-2
Showing results 60 to 71 of 71
| Pub Year | | Title | Author(s) |
| 2022 | | Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial | 허중연 |
| 2022 | | SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses | SHAH, MASAUD, 문승욱, 우현구 |
| 2022 | | Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network | 박래웅, 최영화 |
| 2022 | | Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea | 이순영 |
| 2023 | | Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity | 허중연 |
| 2023 | | The Impact of Omicron Wave on Pediatric Febrile Seizure | 고유라, 양희원, 이지숙, 최유진 |
| 2022 | | The paradigm of immune escape by SARS-CoV-2 variants and strategies for repositioning subverted mAbs against escaped VOCs | SHAH, MASAUD, 우현구 |
| 2021 | | Ultra-fast and recyclable DNA biosensor for point-of-care detection of SARS-CoV-2 (COVID-19) | 김미란 |
| 2022 | | Update on Extracellular Vesicle-Based Vaccines and Therapeutics to Combat COVID-19 | 최용준 |
| 2021 | | Update on liver disease management during the pandemic of coronavirus disease 2019 (Covid-19): 2021 kasl guideline | 김순선 |
| 2022 | | Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment | 김영롱, 유진세, 허중연 |
| 2023 | | Viral shedding patterns of symptomatic SARS-CoV-2 infections by periods of variant predominance and vaccination status in Gyeonggi Province, Korea | 이순영 |
